This MedLibrary.org supplementary page on ATC code M05 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
A section of the Anatomical Therapeutic Chemical Classification System.
Contents |
M05B Drugs affecting bone structure and mineralization
M05BA Bisphosphonates
- M05BA01 Etidronic acid
- M05BA02 Clodronic acid
- M05BA03 Pamidronic acid
- M05BA04 Alendronic acid
- M05BA05 Tiludronic acid
- M05BA06 Ibandronic acid
- M05BA07 Risedronic acid
- M05BA08 Zoledronic acid
M05BB Bisphosphonates and calcium, sequential preparations
- M05BB01 Etidronic acid and calcium
- M05BB02 Risedronic acid and calcium
M05BC Bone morphogenetic proteins
- M05BC01 Dibotermin alfa
- M05BC02 Eptotermin alfa
M05BX Other drugs affecting bone structure and mineralization
- M05BX01 Ipriflavone
- M05BX02 Aluminium chlorohydrate
- M05BX03 Strontium ranelate
|
|||||||||||
Wikipedia content modification information:
- This page was last modified on 18 September 2008, at 03:08.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "ATC code M05".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.